Literature DB >> 24755034

Reconstruction of soft tissue necrosis secondary to cryoglobulinaemia.

Varun Harish1, Andrew P Raymond2, Peter K M Maitz3.   

Abstract

Cryoglobulinaemia is an uncommon immunological disorder that can lead to extensive areas of skin and soft-tissue necrosis. The reconstructive surgeon may be faced with the wound complications of cryoglobulinaemia but there are few case reports in the literature to help guide the reconstructive approach. Moreover, the literature suggests that these wounds are refractory to conventional wound care principles and routine reconstructive practices, and can signify a high risk of morbidity and mortality. We present a case of cryoglobulinaemia leading to severe bilateral lower limb ulceration with necrosis extending through subcutaneous tissues and muscle to the level of bone. Faced with the possibility of above knee amputation, these wounds with exposed bone denuded of periosteum were successfully reconstructed with the dermal regeneration template Pelnac® (Gunze Corp., Kyoto, Japan) and secondary split skin grafting. As far as we are aware, this is the first case reported in the literature where reconstruction was successful, disease remission was achieved, and significant morbidity or mortality did not ensue. We discuss caveats to the reconstruction of soft tissue loss secondary to cryoglobulinaemia, and highlight the multimodal approach to treatment.
Copyright © 2014 British Association of Plastic, Reconstructive and Aesthetic Surgeons. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Acellular dermis; Cryoglobulinaemia; Regeneration; Wound healing

Mesh:

Year:  2014        PMID: 24755034     DOI: 10.1016/j.bjps.2014.03.033

Source DB:  PubMed          Journal:  J Plast Reconstr Aesthet Surg        ISSN: 1748-6815            Impact factor:   2.740


  1 in total

1.  Comparative experimental study of wound healing in mice: Pelnac versus Integra.

Authors:  Ana Carolina Câmara Wosgrau; Talita da Silva Jeremias; Dilmar Francisco Leonardi; Maurício José Pereima; Gabriella Di Giunta; Andrea Gonçalves Trentin
Journal:  PLoS One       Date:  2015-03-23       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.